LQZ-7I, 5mg

LQZ-7I, 5mg

Fezolinetant, 5mg

Fezolinetant, 5mg

LQZ-7I, 25mg

4.269,72 RON
SKU
SKM_E0108_25mg

LQZ-7I is a novel selectively inhibitor of survivin dimerizationwith IC50s of 4.8 µM and 3.1 µM in prostate cancer cell lines PC-3 and C4-2, respectively. LQZ-7I orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors.

Mai multe informatii
Price 3.588,00 RON (preturile sunt fara TVA)
Description

LQZ-7I is a novel selectively inhibitor of survivin dimerizationwith IC50s of 4.8 µM and 3.1 µM in prostate cancer cell lines PC-3 and C4-2, respectively. LQZ-7I orally effectively inhibits xenograft tumor growth and induces survivin loss in tumors.